Daniel Barocas, M.D., MPH, associate professor of Urologic Surgery, recently received the Society of Urologic Oncology’s (SUO) Young Investigator Award at the group’s 2017 annual meeting in Boston.
The award is “recognition by the Society of excellence in clinical practice and/or basic research that has contributed to improvement of clinical care and progress in science.”
“This is a well-deserved honor for Dan. He has done so much for the field already in such a short period of time. I am really proud of him and expect this is just the first of many accolades he will garner in his career,” said David Penson, M.D., professor and chair of Urologic Surgery and the Paul V. Hamilton, M.D., and Virginia E. Howd Professor of Urologic Oncology.
The SUO recognition may be for a singular contribution or a consistent pattern of performance (and contributions) within 10 years of completion of residency or fellowship which have fulfilled the criteria of advancing the field or holds strong promise of doing so in the immediate future.
Jeffrey Holzbeierlein, M.D., director of Urologic Oncology, University of Kansas Medical Center, nominated Barocas for the award.
“I nominated Dr. Barocas for the award because of his outstanding research in the area of health service research and cancer outcomes,” said Holzbeierlein, who was a resident at Vanderbilt from 1994-2000. “He has also done outstanding work on the Committee on Cancer and with his involvement with Young Urologic Oncologists Section (YUO).
